Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Pharmacology|May 4, 2017
Making the Case for 'Power Abuse Disorder' as a Nosologic EntityGerald Zernig, Christoph HiemkePsychopharmacology|September 24, 2008
Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophreniaAxel Becker, Gisela Grecksch, Gerald Zernig, et al.Journal of Psychopharmacology (Oxford, England)|November 3, 2012
Effects of antipsychotic treatment on cognition in healthy subjectsTanja Veselinovic, Holger Schorn, Ingo B Vernaleken, et al.Psychopharmacology|June 7, 2011
Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteersTanja Veselinović, Holger Schorn, Ingo Vernaleken, et al.Behavioural Pharmacology|May 13, 2008
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepamRafal Rygula, Nashat Abumaria, Ursula Havemann-Reinecke, et al.Psychiatry and Clinical Neurosciences|December 16, 2018
Non-adherence to psychotropic medication assessed by plasma level in newly admitted psychiatric patients: Prevalence before acute admissionChristian Geretsegger, Eva-Maria Pichler, Kathrin Gimpl, et al.European Journal of Clinical Pharmacology|April 2, 2010
Serum concentrations of paliperidone versus risperidone and clinical effectsYasmin Nazirizadeh, Friederike Vogel, Wolfgang Bader, et al.Therapeutic Drug Monitoring|February 14, 2025
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNPXenia M Hart, Friederike Amann, Pierre Baumann, et al.Current Drug Delivery|October 30, 2015
Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and NeurologyChristoph HiemkeEuropean Journal of Clinical Pharmacology|January 16, 2008
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatryChristoph HiemkePageof 26